Takeda Pharmaceutical Li... (TAK)

AI Score

Unlock

14.71

0.06 (0.41%)

At close: Apr 17, 2025, 3:59 PM

15.15

2.99%

After-hours: Apr 17, 2025, 07:55 PM EDT

Takeda Pharmaceutical Balance Sheet Statement

Financials in JPY. Fiscal year is April - March.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020	Mar 31, 2019	Mar 31, 2018	Mar 31, 2017
Cash & Equivalents	457.8B	533.53B	849.7B	966.22B	637.61B	702.09B	294.52B	319.45B
Short-Term Investments	15.09B	20.17B	25.3B	36.6B	15.82B	23.28B	80.65B	56.68B
Long-Term Investments	430.61B	378.86B	330.13B	348.35B	369.45B	306.9B	304.38B	303.05B
Other Long-Term Assets	51.21B	63.33B	82.61B	100.34B	103.85B	87.47B	77.98B	54.41B
Receivables	697.61B	681.69B	724.38B	812.71B	784.92B	749.12B	428.79B	444.78B
Inventory	1,209.9B	986.46B	853.17B	753.88B	759.6B	986.74B	212.94B	226.29B
Other Current Assets	193.3B	302.54B	273.26B	180.08B	287.3B	622.15B	61.9B	213.45B
Total Current Assets	2,558.6B	2,398B	2,593.6B	2,712.9B	2,469.4B	3,050.7B	1,078.8B	1,260.7B
Property-Plant & Equipment	1,989.8B	1,691.2B	1,582.8B	1,453.9B	1,386.4B	1,316.5B	536.8B	530.15B
Goodwill & Intangibles	9,684.7B	9,060.4B	8,226.3B	7,943B	8,183.9B	9,021.8B	2,043.5B	2,088.5B
Total Long-Term Assets	12,550.2B	11,559.8B	10,584.4B	10,199.4B	10,351.7B	10,821.7B	3,027.7B	3,095.1B
Total Assets	15,108.8B	13,957.8B	13,178B	12,912.3B	12,821.1B	13,872.3B	4,106.5B	4,355.8B
Account Payables	319.95B	307.45B	295.93B	232.1B	211.63B	212.35B	133.71B	54.88B
Deferred Revenue	n/a	740.74B	644.42B	616.48B	587.98B	627.26B	200.47B	206.38B
Short-Term Debt	367.25B	339.6B	203.99B	22.15B	586.82B	984.95B	18M	545.03B
Other Current Liabilities	1,516B	1,775.3B	1,591.9B	1,468.7B	1,336.4B	1,353.6B	601.66B	693.49B
Total Current Liabilities	2,313.1B	2,481.9B	2,145.7B	1,773.2B	2,175.9B	2,510.9B	737.51B	1,366.1B
Long-Term Debt	4,476.5B	4,042.7B	4,141.4B	4,613.2B	4,506.5B	4,766B	985.64B	599.86B
Other Long-Term Liabilities	377.98B	179.93B	124.8B	188.35B	123.55B	1,110.5B	108.5B	374.92B
Total Long-Term Liabilities	5,521.7B	5,121.1B	5,348.8B	5,961.9B	5,917.7B	6,197.8B	1,351.5B	1,040.7B
Total Liabilities	7,834.8B	7,603.1B	7,494.5B	7,735.1B	8,093.6B	8,708.7B	2,089.1B	2,406.8B
Total Debt	4,843.8B	4,382.3B	4,345.4B	4,635.4B	5,093.3B	5,751B	985.66B	1,144.9B
Common Stock	1,676.6B	1,676.3B	1,676.3B	1,668.1B	1,668.1B	1,643.6B	168.65B	140.18B
Retained Earnings	1,391.2B	1,541.1B	1,479.7B	1,509.9B	1,370B	1,569.4B	1,557.3B	1,511.8B
Comprehensive Income	2,509.3B	1,508.1B	934.17B	366.11B	92.56B	349.88B	-4.79B	291B
Shareholders Equity	7,273.3B	6,354.1B	5,683B	5,173B	4,723.5B	5,159.6B	1,997.4B	1,894.3B
Total Investments	445.7B	99.17B	96.58B	112.47B	107.33B	108.19B	385.03B	359.73B